MAM
MPM Asset Management’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4M | Hold |
4,381,062
| – | – | 67.92% | 1 |
|
|
2025
Q1 | $39.6M | Hold |
4,381,062
| – | – | 57.04% | 1 |
|
|
2024
Q4 | $75.7M | Sell |
4,381,062
-44,722
| -1% | -$773K | 60.89% | 1 |
|
|
2024
Q3 | $70.7M | Hold |
4,425,784
| – | – | 48.68% | 1 |
|
|
2024
Q2 | $63.1M | Hold |
4,425,784
| – | – | 34.64% | 1 |
|
|
2024
Q1 | $62.7M | Hold |
4,425,784
| – | – | 25.58% | 2 |
|
|
2023
Q4 | $66.8M | Hold |
4,425,784
| – | – | 32.82% | 1 |
|
|
2023
Q3 | $69.9M | Hold |
4,425,784
| – | – | 37.45% | 1 |
|
|
2023
Q2 | $67M | Hold |
4,425,784
| – | – | 32.86% | 1 |
|
|
2023
Q1 | $64.2M | Hold |
4,425,784
| – | – | 26.74% | 1 |
|
|
2022
Q4 | $59.8M | Hold |
4,425,784
| – | – | 25.04% | 1 |
|
|
2022
Q3 | $69.8M | Hold |
4,425,784
| – | – | 26.57% | 1 |
|
|
2022
Q2 | $53.9M | Hold |
4,425,784
| – | – | 22.75% | 2 |
|
|
2022
Q1 | $41.6M | Hold |
4,425,784
| – | – | 14.2% | 3 |
|
|
2021
Q4 | $75.8M | Buy |
+4,425,784
| New | +$75.8M | 16.37% | 2 |
|